Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Critical Care
Erschienen in: Critical Care 2/2007

01.04.2007 | Review

Clinical review: Update of avian influenza A infections in humans

verfasst von: Christian Sandrock, Terra Kelly

Erschienen in: Critical Care | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Influenza A viruses have a wide host range for infection, from wild waterfowl to poultry to humans. Recently, the cross-species transmission of avian influenza A, particularly subtype H5N1, has highlighted the importance of the non-human subtypes and their incidence in the human population has increased over the past decade. During cross-species transmission, human disease can range from the asymptomatic to mild conjunctivitis to fulminant pneumonia and death. With these cases, however, the risk for genetic change and development of a novel virus increases, heightening the need for public health and hospital measures. This review discusses the epidemiology, host range, human disease, outcome, treatment, and prevention of cross-transmission of avian influenza A into humans.
Literatur
1.
World Health Organization Expert Committee: A revision of the system of nomenclature for influenza viruses: a WHO Memorandum. Bull WHO 1980, 58: 585-591.
2.
Fouchier RAM, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus AD: Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005, 79: 2814-2822. 10.1128/JVI.79.5.2814-2822.2005PubMedCentralCrossRefPubMed
3.
4.
Kawaoka Y, Webster RG: Molecular mechanism of acquisition of virulence in influenza virus in nature. Microb Pathog 1988, 5: 311-318. 10.1016/0882-4010(88)90032-0CrossRefPubMed
5.
Kendal AP: Epidemiologic implications of changes in the influenza virus genome. Am J Med 1987, 82: 4-14. 10.1016/0002-9343(87)90554-7CrossRefPubMed
6.
Gambaryan AS, Tuzikov AB, Bovin NV, Yamnikova SS, Lvov DK, Webster RG, Matrosovich MN: Differences between influenza virus receptors on target cells of duck and chicken and receptor specificity of the 1997 H5N1 chicken and human influenza viruses from Hong Kong. Avian Dis 2003, 47: 1154-1160.CrossRefPubMed
7.
Ito T, Couceiro JNSS, Kelm S, Baum LG, Krauss S, Castrucci MR, Donatelli I, Kida H, Paulson JC, Webster RG, Kawaoka Y: Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998, 72: 7367-7373.PubMedCentralPubMed
8.
Couceiro JN, Paulson JC, Baum LG: Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium: the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res 1993, 29: 155-165. 10.1016/0168-1702(93)90056-SCrossRefPubMed
9.
Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD: Human and avian influenza (AI) viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 2004, 101: 4620-4624. 10.1073/pnas.0308001101PubMedCentralCrossRefPubMed
10.
Matrosovich M, Zhou N, Kawaoka Y, Webster R: The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol 1999, 73: 1146-1155.PubMedCentralPubMed
11.
Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y: Avian flu: influenza virus receptors in the human airway. Nature 2006, 440: 435-436. 10.1038/440435aCrossRefPubMed
12.
van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T: H5N1 virus attachment to lower respiratory tract. Science 2006, 312: 399. 10.1126/science.1125548CrossRefPubMed
13.
Pensaert M, Ottis K, Vandeputte J, Kaplan MM, Bachmann PA: Evidence for the natural transmission of influenza A virus from wild ducks to swine and its potential importance for man. Bull WHO 1981, 59: 75-78.PubMedCentralPubMed
14.
Scholtissek C, Burger H, Bachmann PA, Hannoun C: Genetic relatedness of hemagglutinins of the H1 subtype of influenza A viruses isolated from swine and birds. Virology 1983, 129: 521-523. 10.1016/0042-6822(83)90194-0CrossRefPubMed
15.
Hinshaw VS, Webster RG, Easterday BC, Bean WJ Jr: Replication of avian influenza A viruses in mammals. Infect Immun 1981, 34: 354-361.PubMedCentralPubMed
16.
Rimmelzwaan GF, van Riel D, Baars M, Bestebroer TM, van Amerongen G, Fouchier RA, Osterhaus AD, Kuiken T: Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 2006, 168: 176-183. 10.2353/ajpath.2006.050466PubMedCentralCrossRefPubMed
17.
Keawcharoen J, Oraveerakul K, Kuiken T, Fouchier RA, Amonsin A, Payungporn S, Noppornpanth S, Wattanodorn S, Theambooniers A, Tantilertcharoen R, et al.: Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004, 10: 2189-2191.PubMedCentralCrossRefPubMed
18.
Englund L, Klingeborn B, Mejerland T: Avian influenza A virus causing an outbreak of contagious interstitial pneumonia in mink. Acta Vet Scand 1986, 27: 497-504.PubMed
19.
Klingeborn B, Englund L, Rott R, Juntti N, Rockborn G: An avian influenza A virus killing a mammalian species – the mink. Brief report. Arch Virol 1985, 86: 347-351. 10.1007/BF01309839CrossRefPubMed
20.
Hinshaw VS, Bean WJ, Geraci J, Fiorelli P, Early G, Webster RG: Characterization of two influenza A viruses from a pilot whale. J Virol 1986, 58: 655-656.PubMedCentralPubMed
21.
Guo Y, Wang M, Zheng GS, Li WK, Kawaoka Y, Webster RG: Seroepidemiological and molecular evidence for the presence of two H3N8 equine influenza viruses in China in 1993–94. J Gen Virol 1995, 76: 2009-2014.CrossRefPubMed
22.
Guo Y, Wang M, Kawaoka Y, Gorman O, Ito T, Saito T, Webster RG: Characterization of a new avian-like influenza A virus from horses in China. Virology 1992, 188: 245-255. 10.1016/0042-6822(92)90754-DCrossRefPubMed
23.
Callan RJ, Early G, Kida H, Hinshaw VS: The appearance of H3 influenza viruses in seals. J Gen Virol 1995, 76: 199-203.CrossRefPubMed
24.
Hinshaw VS, Bean WJ, Webster RG, Rehg JE, Fiorelli P, Early G, Geraci JR, St Aubin DJ: Are seals frequently infected with avian influenza viruses? J Virol 1984, 51: 863-865.PubMedCentralPubMed
25.
Webster RG, Hinshaw VS, Bean WJ, Van Wyke KL, Geraci JR, St Aubin DJ, Petursson G: Characterization of an influenza A virus from seals. Virology 1981, 113: 712-724. 10.1016/0042-6822(81)90200-2CrossRefPubMed
26.
Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, Chen L, Smith C, Hill RC, Ferro P, Pompey J, et al.: Transmission of equine influenza virus to dogs. Science 2005, 310: 482-485. 10.1126/science.1117950CrossRefPubMed
27.
Roberton SI, Bell DJ, Smith GJ, Nicholls JM, Chan KH, Nguyen DT, Tran PQ, Streicher U, Poon LL, Chen H, et al.: Avian influenza H5N1 in viverrids: implications for wildlife health and conservation. Proc R Soc B 2006, 273: 1729-1732. 10.1098/rspb.2006.3549PubMedCentralCrossRefPubMed
28.
Banks J, Speidel E, Alexander DJ: Characterization of an avian influenza A virus isolated from a human – is an intermediate host necessary for the emergence of pandemic influenza viruses? Arch Virol 1998, 143: 781-787. 10.1007/s007050050329CrossRefPubMed
29.
Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG: Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998, 351: 472-477. 10.1016/S0140-6736(97)11212-0CrossRefPubMed
30.
Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, et al.: Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 2004, 101: 1356-1361. 10.1073/pnas.0308352100PubMedCentralCrossRefPubMed
31.
Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J, et al.: Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998, 279: 393-396. 10.1126/science.279.5349.393CrossRefPubMed
32.
Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y: Evolution and ecology of influenza A viruses. Microbiol Rev 1992, 56: 152-179.PubMedCentralPubMed
33.
Hinshaw VS, Air GM, Gibbs AJ, Graves L, Prescott B, Karunakaran D: Antigenic and genetic characterization of a novel hemagglutinin subtype of influenza A viruses from gulls. J Virol 1982, 42: 865-872.PubMedCentralPubMed
34.
Kawaoka Y, Yamnikova S, Chambers TM, Lvov DK, Webster RG: Molecular characterization of a new hemagglutinin, subtype H14, of influenza A virus. Virology 1990, 179: 759-767. 10.1016/0042-6822(90)90143-FCrossRefPubMed
35.
Rohm C, Zhou N, Suss J, Mackenzie J, Webster RG: Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes. Virology 1996, 217: 508-516. 10.1006/viro.1996.0145CrossRefPubMed
36.
Ellis TM, Bousfield RB, Bissett LA, Dyrting KC, Luk GS, Tsim ST, Sturm-Ramirez K, Webster RG, Guan Y, Malik Peiris JS: Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002. Avian Pathol 2004, 33: 492-505. 10.1080/03079450400003601CrossRefPubMed
37.
Liu J, Xiao H, Lei F, Zhu Q, Qin K, Zhang XW, Zhang XL, Zhao D, Wang G, Feng Y, et al.: Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 2005, 309: 1206. 10.1126/science.1115273CrossRefPubMed
38.
Sturm-Ramirez KM, Ellis T, Bousfield B, Bissett L, Dyrting K, Rehg JE, Poon L, Guan Y, Peiris M, Webster RG: Reemerging H5N1 viruses in Hong Kong in 2002 are highly pathogenic to ducks. J Virol 2004, 78: 4892-4901. 10.1128/JVI.78.9.4892-4901.2004PubMedCentralCrossRefPubMed
39.
Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, Rahardjo AP, Puthavathana P, Buranathai C, Nguyen TD, et al.: Genesis of a highly pathogenic and potentially pandemic H5N1 virus in eastern Asia. Nature 2004, 430: 209-213. 10.1038/nature02746CrossRefPubMed
40.
Kou Z, Lei FM, Yu J, Fan ZJ, Yin ZH, Jia CX, Xiong KJ, Sun YH, Zhang XW, Wu XM, et al.: New genotype of avian influenza H5N1 viruses isolated from tree sparrows in China. J Virol 2005, 79: 15460-15466. 10.1128/JVI.79.24.15460-15466.2005PubMedCentralCrossRefPubMed
41.
Mase M, Tsukamoto K, Imada T, Imai K, Tanimura N, Nakamura K, Yamamoto Y, Hitomi T, Kira T, Nakai T, et al.: Characterization of H5N1 influenza A viruses isolated during the 2003–2004 influenza outbreaks in Japan. Virology 2005, 332: 167-176. 10.1016/j.virol.2004.11.016CrossRefPubMed
42.
Van Borm S, Thomas I, Hanquet G, Lambrecht B, Boschmans M, Dupont G, Decaestecker M, Snacken R, van den Berg T: Highly pathogenic H5N1 influenza virus in smuggled Thai Eagles, Belgium. Emerg Infect Dis 2005, 11: 702-705.PubMedCentralCrossRefPubMed
43.
Chen H, Smith GJ, Li KS, Wang J, Fan XH, Rayner JM, Vijaykrishna D, Zhang JX, Zhang LJ, Guo CT, et al.: Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci USA 2006, 103: 2845-2850. 10.1073/pnas.0511120103PubMedCentralCrossRefPubMed
44.
Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, Seiler P, Govorkova EA, Krauss S, Scholtissek C, Puthavathana P, Buranathai C, Nguyen TD, et al.: Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci USA 2005, 102: 10682-10687. 10.1073/pnas.0504662102PubMedCentralCrossRefPubMed
45.
Webster RG, Yakhno M, Hinshaw VS, Bean WJ, Murti KG: Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 1978, 84: 268-278. 10.1016/0042-6822(78)90247-7CrossRefPubMed
46.
Ito T, Okazaki K, Kawaoka Y, Takada A, Webster RG, Kida H: Perpetuation of influenza A viruses in Alaskan waterfowl reservoirs. Arch Virol 1995, 140: 1163-1172. 10.1007/BF01322743CrossRefPubMed
47.
48.
Munster VJ, Wallensten A, Baas C, Rimmelzwaan GF, Schutten M, Olsen B, Osterhaus AD, Fouchier RA: Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg Infect Dis 2005, 11: 1545-1551.PubMedCentralCrossRefPubMed
49.
50.
Webster RG, Geraci J, Petursson G, Skirnisson K: Conjunctivitis in human beings caused by influenza A virus of seals. N Engl J Med 1981, 304: 911.PubMed
51.
Kurtz J, Manvell RJ, Banks J: Avian influenza virus isolated from a woman with conjunctivitis. Lancet 1996, 348: 901-902. 10.1016/S0140-6736(05)64783-6CrossRefPubMed
52.
Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge KF: Human infection with influenza H9N2. Lancet 1999, 354: 916-917. 10.1016/S0140-6736(99)03311-5CrossRefPubMed
53.
Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, Meijer A, van Steenbergen J, Fouchier R, Osterhaus A, Bosman A: Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004, 363: 587-593. 10.1016/S0140-6736(04)15589-XCrossRefPubMed
54.
Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, Cheung PT, To WK, Ho ET, Sung R, Cheng AF: Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998, 351: 467-471. 10.1016/S0140-6736(98)01182-9CrossRefPubMed
55.
Chan PKS: Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002,34(Suppl 2):S58-S64. 10.1086/338820CrossRefPubMed
56.
Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, et al.: Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004, 363: 617-619. 10.1016/S0140-6736(04)15595-5CrossRefPubMed
57.
58.
Tweed SA, Skowronski DM, David ST, Larder A, Petric M, Lees W, Li Y, Katz J, Krajden M, Tellier R, et al.: Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 2004, 10: 2196-2199.PubMedCentralCrossRefPubMed
59.
Katz JM, Lim W, Bridges CB, Rowe T, Hu-Primmer J, Lu X, Abernathy RA, Clarke M, Conn L, Kwong H, et al.: Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999, 180: 1763-1770. 10.1086/315137CrossRefPubMed
60.
Buxton Bridges C, Katz JM, Seto WH, Chan PK, Tsang D, Ho W, Mak KH, Lim W, Tam JS, Clarke M, et al.: Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 2000, 181: 344-348. 10.1086/315213CrossRefPubMed
61.
Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, et al.: Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005, 352: 333-340. 10.1056/NEJMoa044021CrossRefPubMed
62.
Liem NT, Lim W, World Health Organization International Avian Influenza Investigation Team, Vietnam: Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis 2005, 11: 210-215.PubMedCentralCrossRefPubMed
63.
Schultsz C, Dong VC, Chau NV, Le NT, Lim W, Thanh TT, Dolecek C, de Jong MD, Hien TT, Farrar J: Avian influenza H5N1 and healthcare workers. Emerg Infect Dis 2005, 11: 1158-1159.PubMedCentralCrossRefPubMed
64.
65.
Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, Pham TS, Vo CD, Le TQ, Ngo TT, et al.: Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004, 350: 1179-1188. 10.1056/NEJMoa040419CrossRefPubMed
66.
Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R, Lochindarat S, Srisan P, Suwan P, Osotthanakorn Y, et al.: Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005, 11: 201-209.PubMedCentralCrossRefPubMed
67.
The Writing Committee of the World Health Organization (WHO) Consultation on human influenza A/H5: Avian influenza A (H5N1) infection in humans. N Engl J Med 2005, 353: 1374-1385. 10.1056/NEJMra052211CrossRef
68.
de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld M, Le TP, Truong HK, Nguyen VV, et al.: Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005, 352: 686-691. 10.1056/NEJMoa044307CrossRefPubMed
69.
Gruber PC, Gomersall CD, Joynt GM: Avian influenza (H5N1): implications for intensive care. Intensive Care Med 2006, 32: 823-829. 10.1007/s00134-006-0148-zCrossRefPubMed
70.
Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS: Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002, 360: 1831-1837. 10.1016/S0140-6736(02)11772-7CrossRefPubMed
71.
To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, Tang NL, Tsang DN, Sung RY, Buckley TA, et al.: Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 2001, 63: 242-246. 10.1002/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-NCrossRefPubMed
72.
Bridges CB, Lim W, Hu-Primmer J, Sims L, Fukuda K, Mak KH, Rowe T, Thompson WW, Conn L, Lu X, et al.: Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997–1998. J Infect Dis 2002, 185: 1005-1010. 10.1086/340044CrossRefPubMed
73.
Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, Lohman K, Daum LT, Suarez DL: Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 2002, 40: 3256-3260. 10.1128/JCM.40.9.3256-3260.2002PubMedCentralCrossRefPubMed
74.
Lee CW, Suarez DL: Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus. J Virol Methods 2004, 119: 151-158. 10.1016/j.jviromet.2004.03.014CrossRefPubMed
75.
Payungporn S, Phakdeewirot P, Chutinimitkul S, Theamboonlers A, Keawcharoen J, Oraveerakul K, Amonsin A, Poovorawan Y: Single-step multiplex reverse transcription-polymerase chain reaction (RT-PCR) for influenza A virus subtype H5N1 detection. Viral Immunol 2004, 17: 588-593. 10.1089/vim.2004.17.588CrossRefPubMed
76.
The World Health Organization Global Influenza Program Surveillance Network: Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005, 11: 1515-1521.PubMedCentralCrossRef
77.
Regoes RR, Bonhoeffer S: Emergence of drug-resistant influenza virus: population dynamical considerations. Science 2006, 312: 389-391. 10.1126/science.1122947CrossRefPubMed
78.
Hammer SM, Inouye RT: Antiviral agents. In Clinical Virology. 2nd edition. Edited by: Richman DD, Whitley RJ, Hayden FG. Washington DC: ASM Press; 2002:171-242.
79.
De Clercq E: Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 2006, 5: 1015-1025. 10.1038/nrd2175CrossRefPubMed
80.
Jefferson TO, Demicheli V, Di Pietrantonj C, Jones M, Rivetti D: Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Databse Syst Rev 2006, 3: CD001265.
81.
Cass LM, Efthymiopoulos C, Bye A: Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Clin Pharmacokinet 1999,36(Suppl 1):1-11. 10.2165/00003088-199936001-00001CrossRefPubMed
82.
Massarella JW, He GZ, Dorr A, Nieforth K, Ward P, Brown A: The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers. J Clin Pharmacol 2000, 40: 836-843. 10.1177/00912700022009567CrossRefPubMed
83.
Leneva IA, Roberts N, Govorkova EA, Goloubeva OG, Webster RG: The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. Antiviral Res 2000, 48: 101-115. 10.1016/S0166-3542(00)00123-6CrossRefPubMed
84.
Govorkova EA, Fang HB, Tan M, Webster RG: Neuraminidase inhibitorrimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrob Agents Chemother 2004, 48: 4855-4863. 10.1128/AAC.48.12.4855-4863.2004PubMedCentralCrossRefPubMed
85.
Leneva IA, Goloubeva O, Fenton RJ, Tisdale M, Webster RG: Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals. Antimicrob Agents Chemother 2001, 45: 1216-1224. 10.1128/AAC.45.4.1216-1224.2001PubMedCentralCrossRefPubMed
86.
Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y: Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004, 364: 759-765. 10.1016/S0140-6736(04)16934-1CrossRefPubMed
87.
de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, et al.: Oseltamivir resistance during treatment of influenza A (H5N1) infection. New Engl J Med 2005, 353: 2667. 10.1056/NEJMoa054512CrossRefPubMed
88.
Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, et al.: Avian flu: isolation of drug-resistant H5N1 virus. Nature 2005, 437: 1108. 10.1038/4371108aCrossRefPubMed
89.
Sidwell RW, Bailey KW, Wong MH, Barnard DL, Smee DF: In vitro and in vivo influenza virus inhibitory effects of viramidine. Antiviral Res 2005, 68: 10-17. 10.1016/j.antiviral.2005.06.003CrossRefPubMed
90.
Cheng VC, Tang BS, Wu AK, Chu CM, Yuen KY: Medical treatment of viral pneumonia including SARS in immunocompetent adult. J Infect 2004, 49: 262-273. 10.1016/j.jinf.2004.07.010CrossRefPubMed
91.
Nicholson KG, Colegate AE, Podda A, Stephenson I, Wood J, Ypma E, Zambon MC: Safety and antigenicity of non-adjuvanted and F59-adjuvanted influenza A/Duck/Singapore/97 (h5N3) vaccine: a randomized trial of two potential vaccines against H5N1 influenza. Lancet 2001, 357: 1937-1943. 10.1016/S0140-6736(00)05066-2CrossRefPubMed
92.
Stephenson I, Bugarini R, Nicholson KG, Podda A, Wood JM, Zambon MC, Katz JM: Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. J Infect Dis 2005, 191: 1210-1215. 10.1086/428948CrossRefPubMed
93.
Treanor JJ, Wilkinson BE, Masseoud F, Hu-Primmer J, Battaglia R, O'Brien D, Wolff M, Rabinovich G, Blackwelder W, Katz JM: Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 2001, 19: 1732-1737. 10.1016/S0264-410X(00)00395-9CrossRefPubMed
94.
Lipatov AS, Webby RJ, Govorkova EA, Krauss S, Webster RG: Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis 2005, 191: 1216-1220. 10.1086/428951CrossRefPubMed
95.
Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M: Saftey and immunogenicity of an inactivated subviron influenza A (H5N1) vaccine. New Engl J Med 2006, 354: 1343-1351. 10.1056/NEJMoa055778CrossRefPubMed
96.
97.
Yu IT, Li Y, Wong TW, Tam W, Chan AT, Lee JH, Leung DY, Ho T: Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med 2004, 350: 1731-1739. 10.1056/NEJMoa032867CrossRefPubMed
98.
Fowler RA, Lapinsky SE, Hallett D, Detsky AS, Sibbald WJ, Slutsky AS, Stewart TE, Toronto SARS Critical Care Group: Critically ill patients with severe acute respiratory distress syndrome. JAMA 2003, 290: 367-373. 10.1001/jama.290.3.367CrossRefPubMed
99.
Metadaten
Titel
Clinical review: Update of avian influenza A infections in humans
verfasst von
Christian Sandrock
Terra Kelly
Publikationsdatum
01.04.2007
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 2/2007
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc5675

Weitere Artikel der Ausgabe 2/2007

Critical Care 2/2007 Zur Ausgabe

Review

Clinical review: Mass casualty triage – pandemic influenza and critical care

Erratum

Erratum to: Management of bleeding following major trauma: a European guideline

Research

Minimally invasive cardiopulmonary bypass: does it really change the outcome?

Commentary

Recently published papers: Tracheostomy: why rather than when? Obesity: does it matter? And stroke: diagnosis, thrombosis and prognosis

Research

Computer simulation allows goal-oriented mechanical ventilation in acute respiratory distress syndrome

Research

Identification of high-risk subgroups in very elderly intensive care unit patients

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 | Pankreaskarzinom | Nachrichten

S3-Leitlinie zu Pankreaskrebs aktualisiert
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren